Column Group L P Ngm Biopharmaceuticals Inc (NGM) insider trading activity

NGM Quotes by TradingView

Column Group L P is Director of NGM BIOPHARMACEUTICALS INC. Currently has a direct ownership of 0 shares of NGM, which is worth approximately $0. The most recent transaction as insider was on Jun 13, 2019, when has been sold 11,500 shares (Common Stock) at a price of $14.13 per share, resulting in proceeds of $162,495. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

COLUMN GROUP L P Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 13 2019
BUY
Open market or private purchase
$162,495 $14.13 p/Share
11,500 Added 0.55%
2,067,623 Common Stock
Jun 12 2019
BUY
Open market or private purchase
$105,000 $14.0 p/Share
7,500 Added 0.36%
2,056,123 Common Stock
Jun 11 2019
BUY
Open market or private purchase
$150,747 $13.83 p/Share
10,900 Added 0.53%
2,048,623 Common Stock
Jun 07 2019
BUY
Open market or private purchase
$172,116 $13.66 p/Share
12,600 Added 0.61%
2,037,723 Common Stock
Jun 06 2019
BUY
Open market or private purchase
$168,840 $13.4 p/Share
12,600 Added 0.62%
2,025,123 Common Stock
Jun 04 2019
BUY
Open market or private purchase
$168,714 $13.39 p/Share
12,600 Added 0.62%
2,012,523 Common Stock
May 20 2019
BUY
Open market or private purchase
$675,000 $13.5 p/Share
50,000 Added 2.44%
1,999,923 Common Stock
May 10 2019
BUY
Open market or private purchase
$248,234 $13.85 p/Share
17,923 Added 0.91%
1,949,923 Common Stock
May 07 2019
BUY
Open market or private purchase
$803,700 $14.1 p/Share
57,000 Added 2.87%
1,932,000 Common Stock
Apr 08 2019
BUY
Open market or private purchase
$30,240,000 $16.0 p/Share
1,890,000 Added 99.21%
15,000 Common Stock
Apr 08 2019
BUY
Conversion of derivative security
-
13,093,134 Added 49.11%
13,569,091 Common Stock

Also insider at

IMDZ
IMMUNE DESIGN CORP.
> 10% Shareholder
CNST
CONSTELLATION PHARMACEUTICALS INC Healthcare
> 10% Shareholder
NRIX
Nurix Therapeutics, Inc. Healthcare
> 10% Shareholder
CGL

Column Group L P

Director
San Francisco, CA

Track Institutional and Insider Activities on NGM

Follow NGM BIOPHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NGM shares.

Notify only if

Insider Trading

Get notified when an Ngm Biopharmaceuticals Inc insider buys or sells NGM shares.

Notify only if

News

Receive news related to NGM BIOPHARMACEUTICALS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NGM